Live feed21:16:15·513dINSIDERFilingvia QuantisnowSVP, Chief Development Officer Bala Mohan converted options into 8,750 shares and sold $2,147 worth of shares (3,253 units at $0.66), increasing direct ownership by 10% to 60,228 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.MRSN· Mersana Therapeutics Inc.Health CareOriginal source